Vagal Nerve Stimulation for Glycemic Control in a Rodent Model of Type 2 Diabetes

Area of Science:

• Neuroscience
• Endocrinology
• Diabetology

Background:

• Vagal nerve stimulation (VNS) is known to aid weight management and balance the autonomic nervous system.
• However, its impact on glycemic control remains incompletely understood.
• This study investigates VNS effects on blood glucose and underlying mechanisms in a rodent model.

Purpose of the Study:

• To explore the effects of VNS on blood glucose regulation in rats.
• To identify optimal VNS parameters for glycemic control.
• To elucidate the mechanisms by which VNS influences blood glucose levels.

Main Methods:

• Vagal nerve stimulation (VNS) parameters were optimized using a glucagon-induced hyperglycemic rat model.
• A type 2 diabetic rat model (high-fat diet and streptozotocin) was used for validation.
• Electrodes were implanted on the dorsal subdiaphragmatic vagus, with electrocardiogram monitoring.

Main Results:

• VNS with a short pulse width (0.3 ms) significantly reduced blood glucose during oral glucose tolerance tests (OGTT).
• A low frequency of 5 Hz VNS, but not higher frequencies, lowered blood glucose levels during OGTT.
• Intermittent VNS demonstrated greater efficacy than continuous VNS, with enhanced vagal activity observed.

Conclusions:

• VNS at 5 Hz significantly reduces blood glucose in diabetic rats.
• The hypoglycemic effect is mediated by enhanced vagal efferent activity.
• Glucagon-like peptide-1 (GLP-1) release plays a crucial role in VNS-induced glucose reduction, as evidenced by blockade with exendin-4.